Home
About Us
Our Team
The Urihk Partnership
Products
Antibiotic
Antifungal
Antioxidant
Immuno modulator
Neuro/CNS
Services
Learn More
News
Gallery
Careers
Contact Us
Select Page
Back
Oct 25, 2021
Study- Activities of Faropenem, an Oral β-Lactam, against Recent U.S. Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Oct 25, 2021
The efficacy of faropenem for patients with acute cystitis caused by extended spectrum β-lactamase producing Escherichia coli
Oct 25, 2021
Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic
Oct 25, 2021
Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults
Oct 25, 2021
Expert Review – Faropenem medoxomil: a treatment option in acute bacterial rhinosinusitis
Oct 25, 2021
Activity of faropenem against cephalosporin-resistant Enterobacteriaceae
